The global drug screening market is forecast to grow at a compound annual growth rate (CAGR) of more than 9% during the forecast period from 2021-2030.
A drug screening test detects illegal and prescription drugs in the body fluids such as blood, urine, or saliva. It also helps determine how much of a drug a person is using, and it’s an important part of continuing treatment and evaluation.
Request To Download Free Sample of This Strategic Report @https://reportocean.com/industry-verticals/sample-request?report_id=BWCC650
Factors Affecting
- The number of people abusing drugs is rising around the world. According to the World Drug Report 2019, in 2017, approximately 5.5% of the worldwide population aged 15-64 consumed drugs at least once. In 2017, there were 35 million people with substance use disorders, a gain of 14.8% from 30.5 million in 2016. Drug use led to the deaths of 585,000 people in the same year. Globally, drugs cause the loss of 28 million years of healthy life (disability-adjusted life years, or DALYs). Authorities in various countries implement comprehensive drug-testing measures to curb the menace of drug abuse. Thus, drug screening will be in high demand in the coming years.
- The rise in consumption of alcohol and illicit drugs, the establishment of stricter laws in different countries, and increased government funding to combat drug trafficking create an opportunity for drug screening devices.
- The primary restraints for the growth of the global drug screening market include the inaccuracy of breathalyzers, alcohol consumption bans in various countries, and privacy issues associated with drug testing.
Impact Analysis of COVID-19
COVID-19 has led to significant disruptions to business and economic activities that will have a short-term negative impact on the drug screening market due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and concerns about transmission of infection. Governments globally have put forward guidelines to postpone and delay non-essential procedures to ease the strain on the healthcare system and decrease the spread of diseases. Several countries worldwide announced nationwide lockdowns and the closure of production, manufacturing, and business development. Additionally, trade barriers have contributed to a demand-supply deficit. There have been disruptions in the global supply chain, declines in demand, or suspensions in operations by customers for companies operating in the drug screening market.
Regional Overview
North America dominated the overall market, followed by Europe. Factors contributing to the dominance of the North American market include the consumption of illicit drugs, the availability of government funding to combat drug abuse, drug screening laws, and the increasing risk of accidents due to unsafe alcohol consumption.
Leading Companies
The leading prominent companies profiled in the global drug screening market are:
- LabCorp (U.S.)
- Quest Diagnostics (U.S.)
- Alere (U.S.)
- OraSure (U.S.)
- Alfa Scientific Designs (U.S.)
- Thermo Fisher Scientific (U.S.)
- Drägerwerk (Germany)
- LifeLoc (U.S.)
- MPD Inc. (U.S.)
- Omega Laboratories (U.S.)
- Premier Biotech (U.S.)
- Psychemedics (U.S.)
- Roche (Switzerland)
- Shimadzu (Japan)
- Siemens Healthineers (Germany)
- Other Prominent Players
Scope of the Report
The global drug screening market segmentation focuses on Product and Service, Sample Type, End-User, and Region.
Segmentation based on Product and Service
- Drug Screening Products
- Analytical Instruments
- Immunoassay Analyzers
- Chromatography Instruments
- Breathalyzers
- Fuel-cell Breathalyzers
- Semiconductor Breathalyzers
- Other Breathalyzers
- Rapid Testing Devices
- Urine Testing Devices
- Drug Testing Cups
- Dip Cards
- Drug Testing Cassettes
- Urine Testing Devices
- Oral Fluid Testing Devices
- Consumables
- Assay Kits
- Sample Collection Tubes
- Calibrators & Controls
- Other Consumables
- Analytical Instruments
- Drug Screening Services
Segmentation based on Sample Type
- Urine Samples
- Oral Fluid Samples
- Breath Samples
- Hair Samples
- Other Samples
Segmentation based on End-User
- Workplaces
- Drug Testing Laboratories
- Criminal Justice Systems & Law Enforcement Agencies
- Hospitals
- Drug Treatment Centers
- Individual Users
- Pain Management Centers
- Schools & Colleges
Segmentation based on Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Western Europe
- The UK
- Germany
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Poland
- Russia
- Rest of Eastern Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- South America
- Brazil
- Argentina
- Rest of South America
Table of Content
Chapter 1: Global Drug Screening Industry Overview
Chapter 3: Market Dynamics
Chapter 4: Top Company Profiles
Chapter 5: Global Drug Screening market Competition, by Players
Chapter 6: Global Market Size by Regions
Chapter 7: Global Market Segment by Application
Chapter 8: Global Drug Screening Industry Segment by Type
Chapter 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Chapter 10: Strategies and key policies by Distributors/Suppliers/Traders
Chapter 11: Key Marketing Strategy Analysis, by Market Vendors
Chapter 12: Market Effect Factors Analysis
Chapter 13: Global Drug Screening market Size Forecast (2023-2032).
Continue….
Reasons to Buy This Report
(A) The research provides valuable insights for top administration, policymakers, professionals, product advancements, sales managers, and stakeholders in the market. It helps them make informed decisions and strategize effectively.
(B) The report offers comprehensive analysis of Drug Screening market revenues on a global, regional, and country level, projecting trends until 2032. This data allows companies to assess their market share, identify growth opportunities, and explore new markets.
(C) The research includes segmentation of the Drug Screening market based on types, applications, technologies, and end-uses. This segmentation enables leaders to plan their products and allocate resources based on the expected growth rates of each segment.
(D) Analysis of the Drug Screening market benefits investors by providing insights into market scope, position, key drivers, challenges, restraints, expansion opportunities, and potential threats. This information helps them make informed investment decisions.
(E) The report offers a detailed analysis of competitors, their key strategies, and market positioning. This knowledge allows businesses to better understand the competition and plan their own strategies accordingly.
(F) The study helps evaluate Drug Screening business predictions by region, key countries, and top companies, providing valuable information for investment planning and decision-making.
About Report Ocean:
Report Ocean is a renowned provider of market research reports, offering high-quality insights to clients in various industries. Their goal is to assist clients in achieving their top line and bottom line objectives, thereby enhancing their market share in today’s competitive environment. As a trusted source for innovative market research reports, Report Ocean serves as a comprehensive solution for individuals, organizations, and industries seeking valuable market intelligence.